Dialysis Device And Concentrates Market Forecast 2033

Dialysis Device and Concentrates Market Outlook (2023 to 2033)

Global dialysis device and concentrates market demand is anticipated to be valued at US$ 21,663.5 million in 2023, forecast a CAGR of 4.9% to be valued at US$ 34,824.85 million from 2023 to 2033. Growth is attributed to the increasing prevalence of renal disorders. From 2018 to 2022 a CAGR of 3.1% was registered for the dialysis device and concentrates market.

Dialysis is a treatment technique to compensate for poor or lost kidney function. The kidney function is damaged by acute kidney injury or chronic kidney disease. The most common reasons for kidney diseases are urinary infections, diabetes, and genetic kidney diseases.

Dialysis equipment and accessories are used for artificial blood purification in the end stage of renal disease as well as acute kidney injury in dialysis centers or in-home care settings. Dialysis treatment offers a solution to kidney impairment by artificially filtering the blood. The dialysis process regulates water and salts to clean the blood. Patients with kidney failure need dialysis in order to sustain life.

There are two forms of dialysis treatment namely peritoneal dialysis (PD) and haemodialysis (HD). Hemodialysis is a commonly used dialysis technology that treats circulating blood in the dialysis machine. Blood is cleaned as it passes through a dialyzer to diffuse the waste products in dialysis concentrate.

Attributes	Details
Dialysis Device and Concentrates Market CAGR (2023 to 2033)	4.9%
Dialysis Device and Concentrates Market Size (2023)	US$ 21,663.5 million
Dialysis Device and Concentrates Market Size (2033)	US$ 34,824.85 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Which are Some Prominent Drivers Spearheading Dialysis Devices and Concentrating Market Growth?

Factors such as the increasing number of patients suffering from hypertension and diabetes and the growing number of end-stage renal disease in patients have been driving the growth of the global dialysis device and concentrate market.

In addition, factors such as technological advancements in products, negligible preference of patients for kidney transplantation, increase in investment for the development of new products, and reimbursement from governments for the treatment of kidney diseases and end-stage renal disease are further expected to propel the growth of the global dialysis and concentrates market.

The global dialysis device and concentrates sector is witnessing steady growth rates with increasing patient populations. The patient population of home hemodialysis (HHD), peritoneal dialysis, and traditional in-center hemodialysis are expected to fuel the growth of the global dialysis device and concentrate the market over the next decade.

For instance –

According to The United States Renal Data System (USRDS)between 2009 and 2019, the percentage of prevalent patients performing home dialysis increased from 8.9% to 13.1%, a relative increase of nearly 50%. Those 13.1% of patients dialyzing at home in 2019 included 1.9% who performed home hemodialysis and 11.2% who performed peritoneal dialysis.

What are the Challenges Faced by the Dialysis Device and Concentrates Industry?

The factors such as product recall, lower awareness of kidney disease treatment modalities, and low adoption of newly developed devices hamper the growth of the global dialysis and concentrates market.

The lack of developed healthcare infrastructure and the low healthcare spending potential of the population are two key factors that result in the slow growth of the dialysis devices and concentrates market. Also, the lack of resources in developing countries is anticipated to be another factor limiting market expansion in the forthcoming period.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Why is North America Emerging as an Opportunistic Dialysis Device and Concentrates Industry?

As per FMI, the North American market is slated to account for 38.6% of the total market share. The growing incidence of diabetes, obesity, blood pressure, and other lifestyle-related disorders in the United States is expected to increase the prevalence of kidney diseases.

In addition to this, the rising geriatric population in the country is another factor that propels the prevalence of dialysis devices and concentrates. As per the Centers for Disease Control and Prevention, nearly 37 million United States adults are affected by CKD currently. These diseases are more common in people aged 65 years or older (38%), than in people aged 45-64 (12%).

For instance, The American Diabetes Association®(ADA), along with DaVita, announced the launch of an interactive digital experience aimed at helping those living with diabetes prevent and manage kidney disease.

With the growing prevalence of CKD, various governmental and non-governmental authorities and organizations are launching initiatives to educate and support the population dealing with kidney diseases.

This is expected to boost the adoption of dialysis devices, further augmenting the growth of the market in the forthcoming years. For instance, according to the USRDS Annual Data Report (United States Renal Data System, 2020). At the end of 2018, there were 7,433 dialysis facilities in the United States, at which 518,749 patients received dialysis.

How is Europe Contributing to the Growth of the Dialysis Device and Concentrates Industry?

In 2022, Europe captured a share of 33.5% in the dialysis devices and concentrates market. Increasing government expenditure in the healthcare sector is expected to boost sales in the forthcoming years. For instance, General government expenditure in the EU on health amounted to € 1 073 billion or 8.0 % of GDP in 2020.

Favorable policies enabling the adoption of technologically advanced medical equipment in the country continue augmenting the growth of the market over the assessment period.

Ongoing research and development in this field are expected to create opportunities for growth for players operating in the market. The rising incidence of such diseases has also encouraged regulatory authorities to accelerate the product development process by initiating funding directives and other aids.

Does the Asia Pacific emerge as an Attractive Dialysis Device and Concentrates Sector?

The Asia Pacific is anticipated to exhibit a significant growth rate in the dialysis devices and concentrates market over the forecast period owing to the rising health awareness, growing prevalence of chronic kidney disease, and increasing government initiatives and investments to reduce the burden of chronic kidney disease.

According to the National Kidney Foundation, the number of cases of kidney failure is expected to surge rapidly in developing countries, such as China and India, where the number of elderly people is increasing. This generates lucrative growth prospects within the Asia Pacific dialysis device and concentrates the market during the forecast period.

Start-up Scenario

The new entrants in the dialysis devices and concentrates market are continually indulging in several collaborations and highly investing in research and development activities to provide more convenient solutions to the healthcare industry verticals. Key start-ups that are leading the development of the market are - Jiangxi Sanxin Medtec Co., Ltd, Advin Health Care, soxapharma, Hemant Surgical Industries Ltd, Shanghai Medco Industry Pvt Ltd, Mitra Industries Pvt. Ltd, and Tom Medical Supplies Co., Ltd.

Tom Medical Supplies Co., Ltd. provides a complete line of dialysis services and products. And are an integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure.

Market Competition

Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and DaVita Healthcare Partners, Inc account for considerable market size, several regional level players are also operating across key growth regions, particularly in the Asia Pacific.

In June 2022 - Asahi Kasei Medical completed the acquisition of Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant contract manufacturing services to pharmaceutical companies.

In February 2022 - Fresenius Medical Care North America announced partnerships with more than 1,000 nephrology providers in the U.S. as part of the new Kidney Care Choices (KCC) models. These partnerships comprise 20 of the 55 approved Kidney Contracting Entities (KCEs) recently announced by the Centers for Medicare and Medicaid Services (CMS).
In March 2021 - DaVita Kidney and Fresenius Medical Care North America announced an extension of the agreement to provide home dialysis in the United States. This agreement included NxStage home hemodialysis (HHD) machines and other dialysis supplies. This initiative is aimed at expanding the home dialysis product portfolio and giving their customers a range of products to choose from.

Key players

Baxter International Inc.
B. Braun Melsungen AG
Fresenius SE & Co. KGaA
DaVita Healthcare Partners, Inc.
Nipro Corporation
Asahi Kasei Medical Co. Ltd.
Mar Cor Purification, Inc.
Nikkiso Co Ltd.
NxStage Medical, Inc.
Rockwell Medical
Farmasol
Browndove Healthcare

Key segments

By Product Type:

Hemodialysis Machine
A.V. Fistula Needle
A.V. Access Graft
Dialysis Catheter
Dialysis Concentrates
Dialyzer
Dialyzer Reprocessing Machine
Hemodialysis Bloodline and Tubing Set
Declotting Device
Water Treatment System
introducer Sheath and Guidewire

By End-User:

In-center Dialysis
Hospitals
Independent Dialysis Centres
Home Dialysis

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Frequently Asked Questions

How Big will be the Dialysis Device and Concentrates Market by 2033?

The market is estimated to reach US$ 34,824.85 million by 2033.

What is the Growth Potential of the Dialysis Device and Concentrates Market?

The growth potential of the dialysis device and concentrates market is 4.9% CAGR through 2033.

Which Region Monopolizes the Market?

North America monopolizes the dialysis device and concentrates market.

Which is the Top Trend in the Dialysis Device and Concentrates Market?

Surging number of hypertension patients is expected to drive the market forward.

What Opportunities Wait for the Market Players?

Prevalence of renal disorders is expected to create opportunity for market players.

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Hemodialysis Machine
5.3.2. A.V. Fistula Needle
5.3.3. A.V. Access Graft
5.3.4. Dialysis Catheter
5.3.5. Dialysis Concentrates
5.3.6. Dialyzer
5.3.7. Dialyzer Reprocessing Machine
5.3.8. Hemodialysis Bloodline and Tubing Set
5.3.9. Declotting Device
5.3.10. Water Treatment System
5.3.11. Introducer Sheath and Guidewire
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
6.3.1. In-center Dialysis
6.3.2. Hospitals
6.3.3. Independent Dialysis Centres
6.3.4. Home Dialysis
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product Type
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product Type
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product Type
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product Type
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product Type
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product Type
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product Type
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product Type
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product Type
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product Type
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product Type
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product Type
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product Type
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product Type
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product Type
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product Type
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Product Type
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Product Type
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Product Type
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Baxter International Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. B. Braun Melsungen AG
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Fresenius SE & Co. KGaA
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. DaVita Healthcare Partners, Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Nipro Corporation
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Asahi Kasei Medical Co. Ltd.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Mar Cor Purification, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Nikkiso Co Ltd.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. NxStage Medical, Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Rockwell Medical
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Farmasol
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Browndove Healthcare
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Dialysis Device And Concentrates Market